Topics:

Alzheimer

Capacity and Informed Consent

A practical framework that can guide psychiatrists through solving problems of capacity and informed consent.

Related content:
Addressing Psychosomatic Illness in the Elderly

Alzheimer

This CME article reviews the pathophysiology and epidemiology of delirium and provides strategies for assessment, prevention, and management of this syndrome.

The latest scientific developments about the brain and how it works were presented this week at the annual meeting of the Society for Neuroscience. Potential new treatments were identified.

Here: 5 new things to know about stroke -- its link with perioperative A-fib; the danger of cocaine; rehab possibilities with an Alzheimer drug; reducing stroke risk with potassium; and a potential screen for occult A-fib after cryptogenic stroke.

This case stresses the importance of identifying cultural issues that arise in mental health clinical encounters.

The SSRIs, although principally targeting serotonin transporter, are complex drugs that might work on other neurotransmitter and receptor systems. It is likely worthwhile to look at the effects of other monoamine and neuropeptide systems on the enzymatic machinery cleaving the amyloid precursor protein.

Vascular surgeons, internists, and neurologists all exist—but why aren’t there any vascular psychiatrists? There certainly is a need.

Here: an update on the current state of CSF fluid-borne markers for Alzheimer disease and what they may portend.

Pages

Subscribe to Alzheimer on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.